Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

BIT:1ELX - Euronext Milan - US5184391044 - Common Stock - Currency: EUR

68.2  +5.4 (+8.6%)

Fundamental Rating

3

1ELX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 13 industry peers in the Personal Care Products industry. While 1ELX seems to be doing ok healthwise, there are quite some concerns on its profitability. 1ELX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

1ELX had positive earnings in the past year.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in each of the past 5 years.
In the past 5 years 1ELX always reported a positive cash flow from operatings.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of -4.38%, 1ELX is doing worse than 92.31% of the companies in the same industry.
1ELX has a Return On Equity of -20.05%. This is amonst the worse of the industry: 1ELX underperforms 92.31% of its industry peers.
With a Return On Invested Capital value of 5.60%, 1ELX is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for 1ELX is below the industry average of 11.95%.
Industry RankSector Rank
ROA -4.38%
ROE -20.05%
ROIC 5.6%
ROA(3y)5.84%
ROA(5y)6.89%
ROE(3y)22.7%
ROE(5y)26.57%
ROIC(3y)9.14%
ROIC(5y)9.86%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of 1ELX has declined.
With a Operating Margin value of 9.03%, 1ELX is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of 1ELX has declined.
1ELX's Gross Margin of 73.85% is fine compared to the rest of the industry. 1ELX outperforms 76.92% of its industry peers.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 9.03%
PM (TTM) N/A
GM 73.85%
OM growth 3Y-18.75%
OM growth 5Y-10.71%
PM growth 3Y-47.93%
PM growth 5Y-26.95%
GM growth 3Y-2.09%
GM growth 5Y-1.48%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ELX is creating some value.
The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
1ELX has less shares outstanding than it did 5 years ago.
1ELX has a worse debt/assets ratio than last year.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.04. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.04, 1ELX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
1ELX has a debt to FCF ratio of 7.70. This is a slightly negative value and a sign of low solvency as 1ELX would need 7.70 years to pay back of all of its debts.
1ELX has a worse Debt to FCF ratio (7.70) than 69.23% of its industry peers.
A Debt/Equity ratio of 1.68 is on the high side and indicates that 1ELX has dependencies on debt financing.
With a Debt to Equity ratio value of 1.68, 1ELX is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF 7.7
Altman-Z 3.04
ROIC/WACC0.72
WACC7.73%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.41 indicates that 1ELX should not have too much problems paying its short term obligations.
The Current ratio of 1ELX (1.41) is better than 61.54% of its industry peers.
1ELX has a Quick Ratio of 1.02. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 1ELX (1.02) is better than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.02
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.99% over the past year.
The earnings per share for 1ELX have been decreasing by -13.41% on average. This is quite bad
The Revenue has decreased by -3.76% in the past year.
1ELX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.98% yearly.
EPS 1Y (TTM)0.99%
EPS 3Y-26.13%
EPS 5Y-13.41%
EPS Q2Q%-32.99%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-1.26%
Revenue growth 5Y0.98%
Sales Q2Q%-9.9%

3.2 Future

The Earnings Per Share is expected to grow by 12.92% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.11% on average over the next years.
EPS Next Y-41.86%
EPS Next 2Y-6.38%
EPS Next 3Y4.53%
EPS Next 5Y12.92%
Revenue Next Year-8.19%
Revenue Next 2Y-3.31%
Revenue Next 3Y-0.89%
Revenue Next 5Y2.11%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.97, which means the current valuation is very expensive for 1ELX.
Based on the Price/Earnings ratio, 1ELX is valued a bit more expensive than the industry average as 76.92% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.15. 1ELX is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 35.03, the valuation of 1ELX can be described as expensive.
84.62% of the companies in the same industry are cheaper than 1ELX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.60. 1ELX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 38.97
Fwd PE 35.03
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued a bit more expensive than the industry average as 76.92% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ELX indicates a slightly more expensive valuation: 1ELX is more expensive than 76.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.29
EV/EBITDA 15.07
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.38%
EPS Next 3Y4.53%

3

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.77%. Purely for dividend investing, there may be better candidates out there.
1ELX's Dividend Yield is slightly below the industry average, which is at 2.60.
1ELX's Dividend Yield is slightly below the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.77%

5.2 History

The dividend of 1ELX is nicely growing with an annual growth rate of 9.59%!
Dividend Growth(5Y)9.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1ELX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of 1ELX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-83.7%
EPS Next 2Y-6.38%
EPS Next 3Y4.53%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (6/30/2025, 7:00:00 PM)

68.2

+5.4 (+8.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-20 2025-08-20/amc
Inst Owners94.12%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap24.53B
Analysts66.11
Price Target59.24 (-13.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.77%
Yearly Dividend2.26
Dividend Growth(5Y)9.59%
DP-83.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)93.44%
Min EPS beat(2)87.87%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)91.1%
Min EPS beat(4)43.76%
Max EPS beat(4)133.75%
EPS beat(8)8
Avg EPS beat(8)120.03%
EPS beat(12)11
Avg EPS beat(12)82.71%
EPS beat(16)15
Avg EPS beat(16)66.99%
Revenue beat(2)0
Avg Revenue beat(2)-2.01%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-1.43%
Revenue beat(8)1
Avg Revenue beat(8)-1.71%
Revenue beat(12)2
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-1.52%
PT rev (1m)-15%
PT rev (3m)-18.19%
EPS NQ rev (1m)-69.1%
EPS NQ rev (3m)-70.04%
EPS NY rev (1m)4.97%
EPS NY rev (3m)5.37%
Revenue NQ rev (1m)-5.38%
Revenue NQ rev (3m)-5.38%
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 38.97
Fwd PE 35.03
P/S 1.94
P/FCF 30.29
P/OCF 18.41
P/B 6.61
P/tB N/A
EV/EBITDA 15.07
EPS(TTM)1.75
EY2.57%
EPS(NY)1.95
Fwd EY2.85%
FCF(TTM)2.25
FCFY3.3%
OCF(TTM)3.71
OCFY5.43%
SpS35.12
BVpS10.32
TBVpS-4.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.38%
ROE -20.05%
ROCE 8.95%
ROIC 5.6%
ROICexc 6.8%
ROICexgc 13.75%
OM 9.03%
PM (TTM) N/A
GM 73.85%
FCFM 6.41%
ROA(3y)5.84%
ROA(5y)6.89%
ROE(3y)22.7%
ROE(5y)26.57%
ROIC(3y)9.14%
ROIC(5y)9.86%
ROICexc(3y)12.1%
ROICexc(5y)13.99%
ROICexgc(3y)27.91%
ROICexgc(5y)31.23%
ROCE(3y)14.59%
ROCE(5y)15.74%
ROICexcg growth 3Y-21.07%
ROICexcg growth 5Y-22.32%
ROICexc growth 3Y-21.66%
ROICexc growth 5Y-23.4%
OM growth 3Y-18.75%
OM growth 5Y-10.71%
PM growth 3Y-47.93%
PM growth 5Y-26.95%
GM growth 3Y-2.09%
GM growth 5Y-1.48%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF 7.7
Debt/EBITDA 3.37
Cap/Depr 73.73%
Cap/Sales 4.14%
Interest Coverage 3.73
Cash Conversion 72.06%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.02
Altman-Z 3.04
F-Score5
WACC7.73%
ROIC/WACC0.72
Cap/Depr(3y)232.17%
Cap/Depr(5y)179.27%
Cap/Sales(3y)10.8%
Cap/Sales(5y)8.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.99%
EPS 3Y-26.13%
EPS 5Y-13.41%
EPS Q2Q%-32.99%
EPS Next Y-41.86%
EPS Next 2Y-6.38%
EPS Next 3Y4.53%
EPS Next 5Y12.92%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-1.26%
Revenue growth 5Y0.98%
Sales Q2Q%-9.9%
Revenue Next Year-8.19%
Revenue Next 2Y-3.31%
Revenue Next 3Y-0.89%
Revenue Next 5Y2.11%
EBIT growth 1Y4.54%
EBIT growth 3Y-19.77%
EBIT growth 5Y-9.83%
EBIT Next Year30.7%
EBIT Next 3Y19.8%
EBIT Next 5Y16.56%
FCF growth 1Y-9.37%
FCF growth 3Y-21.63%
FCF growth 5Y-4.06%
OCF growth 1Y-25.29%
OCF growth 3Y-13.38%
OCF growth 5Y-1.28%